Boston Scientific Valuation
| BSX Stock | EUR 86.00 0.50 0.58% |
At this time, the firm appears to be overvalued. Boston Scientific shows a prevailing Real Value of €63.64 per share. The current price of the firm is €86.0. Our model approximates the value of Boston Scientific from analyzing the firm fundamentals such as Return On Equity of 0.0408, profit margin of 0.06 %, and Current Valuation of 72.27 B as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Boston Scientific's price fluctuation is very steady at this time. Calculation of the real value of Boston Scientific is based on 3 months time horizon. Increasing Boston Scientific's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Boston stock is determined by what a typical buyer is willing to pay for full or partial control of Boston Scientific. Since Boston Scientific is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Boston Stock. However, Boston Scientific's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 86.0 | Real 63.64 | Hype 86.0 | Naive 83.81 |
The real value of Boston Stock, also known as its intrinsic value, is the underlying worth of Boston Scientific Company, which is reflected in its stock price. It is based on Boston Scientific's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Boston Scientific's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Boston Scientific helps investors to forecast how Boston stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Boston Scientific more accurately as focusing exclusively on Boston Scientific's fundamentals will not take into account other important factors: Boston Scientific Total Value Analysis
Boston Scientific is currently estimated to have takeover price of 72.27 B with market capitalization of 62.45 B, debt of 8.91 B, and cash on hands of 2.68 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Boston Scientific fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
72.27 B | 62.45 B | 8.91 B | 2.68 B |
Boston Scientific Investor Information
About 94.0% of the company shares are held by institutions such as insurance companies. The book value of Boston Scientific was currently reported as 12.26. The company has Price/Earnings To Growth (PEG) ratio of 2.51. Boston Scientific had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Boston Scientific's historical financial statements, Boston Scientific is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Boston Scientific Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Boston Scientific has an asset utilization ratio of 39.06 percent. This implies that the Company is making €0.39 for each dollar of assets. An increasing asset utilization means that Boston Scientific is more efficient with each dollar of assets it utilizes for everyday operations.Boston Scientific Ownership Allocation
Boston Scientific holds a total of 1.43 Billion outstanding shares. The majority of Boston Scientific outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Boston Scientific to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Boston Scientific. Please pay attention to any change in the institutional holdings of Boston Scientific as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Boston Scientific Profitability Analysis
The company reported the revenue of 12.68 B. Net Income was 698 M with profit before overhead, payroll, taxes, and interest of 8.68 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Boston Scientific's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Boston Scientific and how it compares across the competition.
About Boston Scientific Valuation
The stock valuation mechanism determines Boston Scientific's current worth on a weekly basis. Our valuation model uses a comparative analysis of Boston Scientific. We calculate exposure to Boston Scientific's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Boston Scientific's related companies.Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts. BOSTON SCIENTIFIC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 38000 people.
8 Steps to conduct Boston Scientific's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Boston Scientific's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Boston Scientific's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Boston Scientific's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Boston Scientific's revenue streams: Identify Boston Scientific's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Boston Scientific's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Boston Scientific's growth potential: Evaluate Boston Scientific's management, business model, and growth potential.
- Determine Boston Scientific's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Boston Scientific's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Boston Stock analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |